Thania Ordaz-Robles
Research Subjects
Research Interests
Thania Ordaz-Robles has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Adam S. Arterbery
The Jackson Laboratory for Genomic Medicine , Farmington, CT
2 shared publications - Adam S. L. Graefe
Berlin Institute of Health at Charité-Universitätsmedizin Berlin
2 shared publications - Anita Bagley
Shriners Children's Northern California, 2425 Stockton Blvd, Sacramento, CA 95817, the United States of America
2 shared publications - Anxhela Gjyshi Gustafson
Shriners Children’s Genomics Institute
2 shared publications - Damian Smedley
William Harvey Research Institute, Queen Mary University of London, London, UK
2 shared publications - Daniel Danis
Berlin Institute of Health at Charité Universitätsmedizin , Luisenstr. 65, 10117, Berlin
2 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Elsevier in SSRN Electronic Journal
Osteogenesis Imperfecta Caused by Ultra-Rare Variants in IFITM5: New Cases and Molecular Studies on Missense Variants
Variants in IFITM5 are a unique cause of osteogenesis imperfecta (OI). The recurrent c.-14C>T leads to classical OI type V, whereas missense variants are considerably rarer and associated with a distinct phenotype. Here we present 3 Mexican boys with IFITM5 missense variants and investigated their cellular and molecular consequences in vitro. Individual 1 (p.Ser40Trp) had a history of 30 fractures, primarily involving both femurs, leading to bone deformities and short stature (height z-score -3.1). Individual 2 (p.Ser40Leu) had bilateral lower extremity deformities at birth and sustained 15 fractures postnatally. Individual 3 (p.Asn48Ser) experienced 6 fractures, all involving the left femur. None exhibited the hallmark features of OI type V, including hyperplastic callus formation or interosseous membrane calcification. Transient transfection in MC3T3-E1 preosteoblasts showed that all 3 IFITM5 variants were aberrantly retained in the endoplasmic reticulum-Golgi compartment, although total protein levels remained normal. In a MEF2-based luciferase assay in MLO-A5 osteocytic cells, the variants failed to elicit a signaling response and exerted dominant negative effects on wild type IFITM5 when co-expressed. Consistently, plasma membrane localization of the wild type protein was reduced in the presence of the mutants. Additional variants identified in ClinVar and gnomAD (p.Ser40Pro, p.Asn48Asp, and p.Asn48His) showed similar intracellular retention and loss of activity. Biochemical analyses indicated loss of palmitoylation of the adjacent cysteine residues. These findings expand the clinical spectrum of IFITM5 missense variants and demonstrate a dominant negative disease mechanism distinct from the classical IFITM5 c.-14C>T variant.
- 22 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessOsteogenesis Imperfecta Caused by Ultra-Rare Variants in IFITM5: New Cases and Molecular Studies on Missense Variants
Variants in IFITM5 are a unique cause of osteogenesis imperfecta (OI). The recurrent c.-14C>T leads to classical OI type V, whereas missense variants are considerably rarer and associated with a distinct phenotype. Here we present 3 Mexican boys with IFITM5 missense variants and investigated their cellular and molecular consequences in vitro. Individual 1 (p.Ser40Trp) had a history of 30 fractures, primarily involving both femurs, leading to bone deformities and short stature (height z-score -3.1). Individual 2 (p.Ser40Leu) had bilateral lower extremity deformities at birth and sustained 15 fractures postnatally. Individual 3 (p.Asn48Ser) experienced 6 fractures, all involving the left femur. None exhibited the hallmark features of OI type V, including hyperplastic callus formation or interosseous membrane calcification. Transient transfection in MC3T3-E1 preosteoblasts showed that all 3 IFITM5 variants were aberrantly retained in the endoplasmic reticulum-Golgi compartment, although total protein levels remained normal. In a MEF2-based luciferase assay in MLO-A5 osteocytic cells, the variants failed to elicit a signaling response and exerted dominant negative effects on wild type IFITM5 when co-expressed. Consistently, plasma membrane localization of the wild type protein was reduced in the presence of the mutants. Additional variants identified in ClinVar and gnomAD (p.Ser40Pro, p.Asn48Asp, and p.Asn48His) showed similar intracellular retention and loss of activity. Biochemical analyses indicated loss of palmitoylation of the adjacent cysteine residues. These findings expand the clinical spectrum of IFITM5 missense variants and demonstrate a dominant negative disease mechanism distinct from the classical IFITM5 c.-14C>T variant.
- Open Access
- 3 September 2026
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 113 (9) , 1972-1986
A phenotypic paradigm for cerebral palsy genetics
- 3 September 2026
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 113 (9) , 1972-1986
Open AccessA phenotypic paradigm for cerebral palsy genetics
- Open Access
A Phenotypic Paradigm for Cerebral Palsy Genetics
Disease-causing genetic variants can be found in a subset of individuals with cerebral palsy (CP), with variants deemed causal of CP having been published for at least 515 genes. We develop a statistical approach that treats CP as a phenotypic feature for which some genetic disorders confer an increased risk. Based on comprehensive literature curation we show that the null hypothesis of no CP association can be rejected for only 89 of the 515 genes. We applied these findings to the analysis of a cohort of 460 children diagnosed with CP in the Shriner Children's network. We identified pathogenic or likely pathogenic (P/LP) variants in 60 genes in 15.8% of the children. Only 16 of the 60 genes had significant evidence for CP association in our literature analysis. Our results suggest that a stratified approach to attributing causality to genetic variants in CP could support precision genomic medicine for affected individuals.
Open AccessA Phenotypic Paradigm for Cerebral Palsy Genetics
Disease-causing genetic variants can be found in a subset of individuals with cerebral palsy (CP), with variants deemed causal of CP having been published for at least 515 genes. We develop a statistical approach that treats CP as a phenotypic feature for which some genetic disorders confer an increased risk. Based on comprehensive literature curation we show that the null hypothesis of no CP association can be rejected for only 89 of the 515 genes. We applied these findings to the analysis of a cohort of 460 children diagnosed with CP in the Shriner Children's network. We identified pathogenic or likely pathogenic (P/LP) variants in 60 genes in 15.8% of the children. Only 16 of the 60 genes had significant evidence for CP association in our literature analysis. Our results suggest that a stratified approach to attributing causality to genetic variants in CP could support precision genomic medicine for affected individuals.
- 25 September 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (2) , 481-489
FLNA Variants Related to Melnick‐Needles Syndrome: Two Mexican Case Reports and a Comprehensive Variant Review
Melnick‐Needles Syndrome (MNS; OMIM #309350) is a rare X‐linked dominant osteochondrodysplasia caused by FLNA gain‐of‐function variants. It is characterized by short stature, facial dysmorphism, skeletal anomalies, and systemic complications. FLNA encodes Filamin A, a cytoskeletal protein with over 90 binding partners. Variants in FLNA cause a broad spectrum of disorders, among which MNS represents one of the most severe phenotypes. Despite increasing research on MNS, many aspects of its genetic and phenotypic spectrum remain unknown. In this work, we presented two Mexican cases with a diagnosis of MNS with different FLNA missense variants p.(Leu1193Pro) and p.(Ser1199Leu). In addition, we performed a comprehensive review of the literature about FLNA variants related to MNS. This study reinforced the genetic and phenotypic complexity of MNS, emphasizing the critical role of exon 22 variants in the pathogenesis of the disease.
- 25 September 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (2) , 481-489
FLNA Variants Related to Melnick‐Needles Syndrome: Two Mexican Case Reports and a Comprehensive Variant Review
Melnick‐Needles Syndrome (MNS; OMIM #309350) is a rare X‐linked dominant osteochondrodysplasia caused by FLNA gain‐of‐function variants. It is characterized by short stature, facial dysmorphism, skeletal anomalies, and systemic complications. FLNA encodes Filamin A, a cytoskeletal protein with over 90 binding partners. Variants in FLNA cause a broad spectrum of disorders, among which MNS represents one of the most severe phenotypes. Despite increasing research on MNS, many aspects of its genetic and phenotypic spectrum remain unknown. In this work, we presented two Mexican cases with a diagnosis of MNS with different FLNA missense variants p.(Leu1193Pro) and p.(Ser1199Leu). In addition, we performed a comprehensive review of the literature about FLNA variants related to MNS. This study reinforced the genetic and phenotypic complexity of MNS, emphasizing the critical role of exon 22 variants in the pathogenesis of the disease.